135 related articles for article (PubMed ID: 8863183)
1. Effects of sodium butyrate on glucose transporter and glucose-phosphorylating enzyme gene expression in RINm5F insulinoma cells.
Tiedge M; Lenzen S
J Mol Endocrinol; 1996 Aug; 17(1):19-26. PubMed ID: 8863183
[TBL] [Abstract][Full Text] [Related]
2. Effect of sodium butyrate on glucose transport and glucose-phosphorylating enzymes in RIN-m5F cells.
Fernandez-Mejia C; Davidson MB
Pancreas; 1993 Sep; 8(5):589-96. PubMed ID: 8302795
[TBL] [Abstract][Full Text] [Related]
3. Insulin secretion, insulin content and glucose phosphorylation in RINm5F insulinoma cells after transfection with human GLUT2 glucose-transporter cDNA.
Tiedge M; Höhne M; Lenzen S
Biochem J; 1993 Nov; 296 ( Pt 1)(Pt 1):113-8. PubMed ID: 8250830
[TBL] [Abstract][Full Text] [Related]
4. Sodium butyrate induces neuroendocrine cytodifferentiation in the insulinoma cell line RINm5F.
Swarovsky B; Eissele R; Eisenacher M; Trautmann ME; Arnold R
Pancreas; 1994 Jul; 9(4):460-8. PubMed ID: 7937695
[TBL] [Abstract][Full Text] [Related]
5. Engineering of a glucose-responsive surrogate cell for insulin replacement therapy of experimental insulin-dependent diabetes.
Tiedge M; Elsner M; McClenaghan NH; Hedrich HJ; Grube D; Klempnauer J; Lenzen S
Hum Gene Ther; 2000 Feb; 11(3):403-14. PubMed ID: 10697115
[TBL] [Abstract][Full Text] [Related]
6. Glucokinase, hexokinase, glucose transporter 2, and glucose metabolism in islets during pregnancy and prolactin-treated islets in vitro: mechanisms for long term up-regulation of islets.
Weinhaus AJ; Stout LE; Sorenson RL
Endocrinology; 1996 May; 137(5):1640-9. PubMed ID: 8612496
[TBL] [Abstract][Full Text] [Related]
7. Novel insulinoma cell lines produced by iterative engineering of GLUT2, glucokinase, and human insulin expression.
Clark SA; Quaade C; Constandy H; Hansen P; Halban P; Ferber S; Newgard CB; Normington K
Diabetes; 1997 Jun; 46(6):958-67. PubMed ID: 9166666
[TBL] [Abstract][Full Text] [Related]
8. Regulation of insulin secretion from novel engineered insulinoma cell lines.
Hohmeier HE; BeltrandelRio H; Clark SA; Henkel-Rieger R; Normington K; Newgard CB
Diabetes; 1997 Jun; 46(6):968-77. PubMed ID: 9166667
[TBL] [Abstract][Full Text] [Related]
9. GLUT2 and glucokinase expression is coordinately regulated by sulfonylurea.
Porzio O; Marlier LN; Federici M; Hribal ML; Magnaterra R; Lauro D; Fusco A; Sesti G; Borboni P
Mol Cell Endocrinol; 1999 Jul; 153(1-2):155-61. PubMed ID: 10459863
[TBL] [Abstract][Full Text] [Related]
10. Sodium butyrate inhibits rat insulinoma cell proliferation without affecting the cellular insulin content or insulin release.
Sjöholm A
Anticancer Drugs; 1993 Apr; 4(2):259-63. PubMed ID: 8490204
[TBL] [Abstract][Full Text] [Related]
11. Beta-cell gene expression and functional characterisation of the human insulinoma cell line CM.
Baroni MG; Cavallo MG; Mark M; Monetini L; Stoehrer B; Pozzilli P
J Endocrinol; 1999 Apr; 161(1):59-68. PubMed ID: 10194529
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells.
Wang Y; Egan JM; Raygada M; Nadiv O; Roth J; Montrose-Rafizadeh C
Endocrinology; 1995 Nov; 136(11):4910-7. PubMed ID: 7588224
[TBL] [Abstract][Full Text] [Related]
13. Inhibitory effects of streptozotocin, tumor necrosis factor-alpha, and interleukin-1beta on glucokinase activity in pancreatic islets and gene expression of GLUT2 and glucokinase.
Park C; Kim JR; Shim JK; Kang BS; Park YG; Nam KS; Lee YC; Kim CH
Arch Biochem Biophys; 1999 Feb; 362(2):217-24. PubMed ID: 9989930
[TBL] [Abstract][Full Text] [Related]
14. GLUT-2 gene transfer into insulinoma cells confers both low and high affinity glucose-stimulated insulin release. Relationship to glucokinase activity.
Ferber S; BeltrandelRio H; Johnson JH; Noel RJ; Cassidy LE; Clark S; Becker TC; Hughes SD; Newgard CB
J Biol Chem; 1994 Apr; 269(15):11523-9. PubMed ID: 8157682
[TBL] [Abstract][Full Text] [Related]
15. Clonal insulinoma cell line that stably maintains correct glucose responsiveness.
Knaack D; Fiore DM; Surana M; Leiser M; Laurance M; Fusco-DeMane D; Hegre OD; Fleischer N; Efrat S
Diabetes; 1994 Dec; 43(12):1413-7. PubMed ID: 7958492
[TBL] [Abstract][Full Text] [Related]
16. Cellular characterization of pituitary adenoma cell line (AtT20 cell) transfected with insulin, glucose transporter type 2 (GLUT2) and glucokinase genes: insulin secretion in response to physiological concentrations of glucose.
Motoyoshi S; Shirotani T; Araki E; Sakai K; Kaneko K; Motoshima H; Yoshizato K; Shirakami A; Kishikawa H; Shichiri M
Diabetologia; 1998 Dec; 41(12):1492-501. PubMed ID: 9867217
[TBL] [Abstract][Full Text] [Related]
17. Hexokinase isoenzymes of RIN-m5F insulinoma cells. Expression of glucokinase gene in insulin-producing cells.
Vischer U; Blondel B; Wollheim CB; Höppner W; Seitz HJ; Iynedjian PB
Biochem J; 1987 Jan; 241(1):249-55. PubMed ID: 3032155
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular characterization of a feline insulinoma.
Jackson TC; Debey B; Lindbloom-Hawley S; Jones BT; Schermerhorn T
J Vet Intern Med; 2009; 23(2):383-7. PubMed ID: 19192149
[TBL] [Abstract][Full Text] [Related]
19. Glucose uptake, utilization, and signaling in GLUT2-null islets.
Guillam MT; Dupraz P; Thorens B
Diabetes; 2000 Sep; 49(9):1485-91. PubMed ID: 10969832
[TBL] [Abstract][Full Text] [Related]
20. Glucosamine-induced beta-cell dysfunction: a possible involvement of glucokinase or glucose-transporter type 2.
Yoshikawa H; Tajiri Y; Sako Y; Hashimato T; Umeda F; Nawata H
Pancreas; 2002 Apr; 24(3):228-34. PubMed ID: 11893929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
